OncoDNA awarded the prize "Most promising company of the year 2015"

Brussels - 19 October 2015
OncoDNA SA (Gosselies, Belgium)  has won the third edition of "Most promising company of the year" organised by EY (formerly Ernst & Young). The laureate won over formidable opponents as Domo Bios & Acar'Up, MyMicroinvest and Universem. 
OncoDNA, a Cancer Theranostic Company, is a European start-up founded in 2012 which provides a personal protection in cancer through the unique combination of DNA sequencing and molecular pathology. More than 2,000 patients in fifty countries have already appealed to OncoDeep, a tool that provides oncologists support treatment choices based on targeted therapies.  
With yhe platform OncoShare the company wants to ensure better communication between the patient, the oncologist, the community of experts-oncologists and OncoDNA.
 Source : ONCODNA

It has among its Board member, Jean Stephenne, former director of GSK Vaccines.

Steven Keating - fighting cancer through curiosity

MARCH 31, 2015
source: http://stevenkeating.info/main.html


The New York times
 http://www.nytimes.com/2015/04/01/technology/the-healing-power-of-your-own-medical-data.html
 

Opening data to patients raises questions. Will worried patients inundate physicians with time-consuming questions? Will sharing patient data add to legal risks? One detail in the yearlong study of OpenNotes underlines doctors’ concerns; 105 primary physicians completed the study, but 143 declined to participate.

Continue reading the main story Continue reading the main story

Continue reading the main story

Still, the experience of the doctors in the evaluation seemed reassuring. Only 3 percent said they spent more time answering patient questions outside of visits. Yet knowing that patients could read the notes, one-fifth of the physicians said they changed the way they wrote about certain conditions, like substance abuse and obesity.

Evidence of the benefit to individuals from sharing information rests mainly on a few studies so far. For example, 55 percent of the members of the epilepsy community on PatientsLikeMe, a patient network, reported that sharing information and experiences with others helped them learn about seizures, and 27 percent said it helped them be more adherent to their medications.